title: The potential effect of gender in CYP1A1 and GSTM1 genotype-specific associations with pediatric brain tumor.
abstract: Brain tumors are the common site for solid tumors in childhood. Very few studies have investigated genes with low penetrance in relation to pediatric brain tumor (pBT) development. Brain tumors do occur more frequently in males compared to females regardless of age, tumor histology, or region of the world. Taken into account these facts, we have designed a study aimed to analyse the contribution of some genetic factors to pBP in males and females. Patients with glial and embryonic brain tumors (160 males, 124 females) and healthy controls (277 males, 187 females) were included in the study. All subjects were genotyped for eight polymorphic variants in the genes of xenobiotics detoxification CYP1A1 (rs2606345, rs4646903, rs1048943), GSTM1 (Ins/del), GSTT1 (Ins/del), repair ERCC2 (rs1799793, rs13181), and folate pathway MTHFR (rs1801133). Genotype-specific risks of pBT were sex-dependent. GSTM1 deletion and dual deletions in GSTM1-GSTT1 loci were associated with brain tumor in males (P = 1.2 × 10(-5); odds ratio (OR) = 2.56; 95 % confidence interval (CI), 1.45-3.85 and P = 4.9 × 10(-4); OR = 3.09; 95 % CI, 1.63-5.89, relatively). The increased risk of brain tumors was evident for CYP1A1 rs2606345 (P = 0.0028; OR = 2.06; 95 % CI, 1.27-3.34) and minor haplotypes rs2606345-rs1048943-rs4646903 in females (global haplotype association P value, 0.0011). This study provides first evidence for the different pronounced pBT associations in males and females. This phenomenon possibly reflects the sexual dimorphism as an important determinant of brain tumor biology.
authors: N.I. Vavilov Institute of General Genetics, Russian Academy of Sciences, 3 Gubkin Street, Moscow, 117971, Russia, salnikovalyubov@gmail.com.
authors: Lyubov E
authors: LE
authors: Salnikova
authors: Olesya B
authors: OB
authors: Belopolskaya
authors: Natalya I
authors: NI
authors: Zelinskaya
authors: Alexander V
authors: AV
authors: Rubanovich
mesh_terms: D000293:Adolescent; D000328:Adult; D001932:Brain Neoplasms / Q000453:epidemiology / Q000235:genetics*; D020295:Brain Stem Neoplasms / Q000453:epidemiology / Q000235:genetics*; D016022:Case-Control Studies; D002648:Child; D019363:Cytochrome P-450 CYP1A1 / Q000235:genetics*; D004843:Epistasis, Genetic; D005260:Female; D056726:Genetic Association Studies; D005909:Glioblastoma / Q000453:epidemiology / Q000235:genetics*; D005982:Glutathione Transferase / Q000235:genetics*; D006239:Haplotypes; D006801:Humans; D015810:Linkage Disequilibrium; D008297:Male; D020641:Polymorphism, Single Nucleotide; D015995:Prevalence; D012307:Risk Factors; D017678:Sex Distribution; D012737:Sex Factors; D055815:Young Adult
chemical_list: D019363:Cytochrome P-450 CYP1A1; D005982:Glutathione Transferase; C569463:CYP1A1 protein, human; C413545:glutathione S-transferase T1
references: Cancer Res. 2005 Apr 1;65(7):2972-8
references: 15805301
references: J Biol Chem. 2001 Apr 20;276(16):12749-55
references: 11278289
references: J Neuroendocrinol. 2006 Aug;18(8):621-8
references: 16867183
references: Childs Nerv Syst. 2005 Nov;21(11):940-4
references: 16044344
references: Cancer Epidemiol Biomarkers Prev. 2008 Feb;17(2):405-13
references: 18268125
references: Cancer Epidemiol Biomarkers Prev. 2011 Nov;20(11):2413-9
references: 21914837
references: Environ Health Perspect. 2005 Jul;113(7):909-13
references: 16002382
references: Biol Sex Differ. 2012 Jan 25;3:3
references: 22277186
references: Pharmacogenet Genomics. 2007 Sep;17(9):709-17
references: 17700360
references: BMC Genomics. 2008 Oct 31;9:516
references: 18976480
references: J Neurooncol. 2012 Oct;110(1):49-57
references: 22886512
references: Drug Metab Pharmacokinet. 2006 Oct;21(5):357-74
references: 17072089
references: PLoS Genet. 2011 Aug;7(8):e1002215
references: 21852955
references: Clin Cancer Res. 2008 Jun 1;14(11):3248-53
references: 18519749
references: Cancer Detect Prev. 2008;32(1):72-8
references: 18406541
references: Brain Res Mol Brain Res. 2005 Jun 13;137(1-2):98-103
references: 15950766
references: Brain Pathol. 2009 Jan;19(1):121-31
references: 19076777
references: Genome Res. 2006 Aug;16(8):995-1004
references: 16825664
references: Expert Rev Mol Diagn. 2001 May;1(1):119-23
references: 11901796
references: Immunogenetics. 2012 Jun;64(6):409-19
references: 22350167
references: Science. 2002 Jun 21;296(5576):2225-9
references: 12029063
references: Pediatr Hematol Oncol. 2012 Nov;29(8):679-85
references: 22994552
references: Environ Health Perspect. 2010 Jan;118(1):144-9
references: 20056567
references: PLoS One. 2008 Jun 11;3(6):e2337
references: 18545703
references: Cancer. 2005 Jun 1;103(11):2363-72
references: 15834925
references: Nat Rev Genet. 2007 Apr;8(4):253-62
references: 17363974
references: Neuro Oncol. 2010 Jan;12(1):37-48
references: 20150366
references: J Surg Res. 2010 May 1;160(1):18-24
references: 19592018
references: Genet Epidemiol. 2002 Oct;23(3):221-33
references: 12384975
references: Epidemiol Perspect Innov. 2011 Feb 02;8(1):1
references: 21288353
references: Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):204-14
references: 19124499
references: Toxicol Sci. 2007 Dec;100(2):513-24
references: 17890767
references: Neuroscience. 2009 Mar 17;159(2):451-67
references: 19171181
references: J Cell Physiol. 2010 Mar;222(3):509-14
references: 19937730
references: Pediatr Blood Cancer. 2012 Oct;59(4):605-10
references: 22389292
references: Toxicol Appl Pharmacol. 2004 Sep 1;199(2):118-31
references: 15313584
references: Mutat Res. 2000 Feb 16;465(1-2):101-11
references: 10708975
references: Environ Health Perspect. 1995 Nov;103 Suppl 8:283-6
references: 8741799
references: Cancer Epidemiol Biomarkers Prev. 2004 Feb;13(2):304-13
references: 14973099
references: Clin Microbiol Rev. 2006 Oct;19(4):763-87
references: 17041143
references: J Neurooncol. 2009 Oct;95(1):37-48
references: 19415456
references: J Cereb Blood Flow Metab. 2007 Jan;27(1):135-41
references: 16736049
references: Bioinformatics. 2006 Aug 1;22(15):1928-9
references: 16720584
references: PLoS One. 2009 May 21;4(5):e5652
references: 19479063
references: Front Oncol. 2011 Oct 24;1:39
references: 22655244
references: Environ Health. 2011 Apr 05;10 Suppl 1:S5
references: 21489215
references: Front Genet. 2012 Nov 28;3:268
references: 23226157
references: Int J Environ Res Public Health. 2010 Jan;7(1):325-32
references: 20195449
references: J Neurooncol. 2002 Sep;59(2):123-34
references: 12241105
references: Trends Pharmacol Sci. 1989 Apr;10(4):149-53
references: 2665247
references: Genomics Inform. 2012 Jun;10(2):117-22
references: 23105939